Dec 23, 2019
Mallinckrodt to Present at the 38th Annual J.P. Morgan Healthcare Conference
Dec 02, 2019
Mallinckrodt Moves Date and Time of Its Fireside Chat at Piper Jaffray Annual Healthcare Conference
Nov 19, 2019
Mallinckrodt to Present at Piper Jaffray Annual Healthcare Conference
Nov 08, 2019
Mallinckrodt to Present at Jefferies London Healthcare Conference
Nov 04, 2019
Mallinckrodt Completes Sale of BioVectra Inc. for up to $250 Million
Sep 20, 2019
Mallinckrodt to Present at Cantor Global Healthcare Conference
Sep 03, 2019
Mallinckrodt Announces Completion of Previously Disclosed Settlement Agreement with U.S. Department of Justice on Legacy Questcor Sales and Marketing Activities
Aug 21, 2019
Mallinckrodt to Present at Morgan Stanley 17th Annual Global Healthcare Conference
Aug 02, 2019
Mallinckrodt to Present at Wells Fargo Securities 2019 Healthcare Conference
Jun 11, 2019
Mallinckrodt to Present at BMO Capital Markets 2019 Prescriptions for Success Healthcare Conference
Jun 05, 2019
Mallinckrodt Announces Agreement In Principle With U.S. Department Of Justice On Legacy Questcor Sales And Marketing Activities; Responds To Government Civil Litigation Involving Legacy Questcor Charitable Foundation Activities
May 21, 2019
Mallinckrodt Announces Election of Carlos V. Paya, M.D., Ph.D. to its Board of Directors
Apr 11, 2019
Mallinckrodt and Washington University St. Louis Select First Collaborative Research Endeavor
Mar 28, 2019
Mallinckrodt Achieves Top Score in 2019 Corporate Equality Index for Third Year in a Row, Recognized as a Best Place to Work for LGBTQ Equality
Mar 18, 2019
Bryan Reasons Joins Mallinckrodt as the Company's Chief Financial Officer (CFO)
Dec 17, 2018
Mallinckrodt To Present At 37th Annual J.P. Morgan Healthcare Conference
Nov 12, 2018
Mallinckrodt To Present At BMO Prescriptions For Success Healthcare Conference
Nov 02, 2018
Leading Hepatorenal Expert Joins Mallinckrodt's Scientific Advisory Council
Oct 08, 2018
U.S. FDA Announces Joint Advisory Committee Review of Mallinckrodt's Abuse-Deterrent, Immediate-Release Reformulation of Roxicodone® (Oxycodone Hydrochloride)
Aug 10, 2018
Mallinckrodt To Present At Wells Fargo Securities 2018 Healthcare Conference